UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013936
Receipt number R000016238
Scientific Title Autotransplantation and culture of cryopreserved ovarian tissue in patients with cancer or immunologic diseases to preserve fertility.
Date of disclosure of the study information 2014/08/01
Last modified on 2016/05/18 14:11:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Autotransplantation and culture of cryopreserved ovarian tissue in patients with cancer or immunologic diseases to preserve fertility.

Acronym

Autotransplantation and culture of cryopreserved ovarian tissue

Scientific Title

Autotransplantation and culture of cryopreserved ovarian tissue in patients with cancer or immunologic diseases to preserve fertility.

Scientific Title:Acronym

Autotransplantation and culture of cryopreserved ovarian tissue

Region

Japan


Condition

Condition

Breast cancer, leukemia, malignant lymphoma (Hodgkin's and Non-Hodgkin's), other hematopoietic diseases (hypoplastic anemia, myelodysplastic syndrome, myeloma), sarcoma, systemic lupus erythematosus, rheumatic arthritis and other diseases requiring alkylating agents or radiation therapies.

Classification by specialty

Medicine in general Surgery in general

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

to preserve fertility

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fertility by autotransplantation of cryopreserved ovarian tissue

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

cryopreservation of ovarian tissue

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

45 years-old >=

Gender

Female

Key inclusion criteria

Patients must meet all of the following:
1 meets the disease and age criteria
2 has a signed informed and consent form
3 as for autotransplantation, must be equal to or under the age 50 and must have a signed consent by the physician treating the primary disease
4 must make an annual visit to the clinic during the period requiring cryopreservation

Key exclusion criteria

Exclusion criteria for cryopreservation:
1 has a serious complication
2 inability to judge or unable to confirm his/her wishes
3 if this study will delay the treatment for the primary disease
4 other situations where the physician treating the primary disease decides the patient unfit for this study

Exclusion criteria for autotransplantation:
1 has a serious complication
2 inability to judge or unable to confirm his/her wishes
3 if autotransplantation is a risk for the patient

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Iwase

Organization

Nagoya University Hospital

Division name

Perinatal Medical Center

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2261

Email

akiwase@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoko Nakamura

Organization

Nagoya University Hospital

Division name

Department of Obstetrics and Gynecology

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2261

Homepage URL


Email

tomonakamura@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Hospital Department of Obstetrics and Gynecology

Institute

Department

Personal name



Funding Source

Organization

Nagoya University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 05 Month 12 Day

Date of IRB


Anticipated trial start date

2014 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 05 Month 12 Day

Last modified on

2016 Year 05 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016238


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name